SCHEMBL4245347

SCHEMBL4245347

NC(=O)c1ccc(O)cc1.O=C(O)N1CCC(CSc2ccccc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GAA P10253 1/20 0.44
GRIN2B Q13224 4/20 0.40
GRIN2A Q12879 3/20 0.40
GRIN1 Q05586 3/20 0.39
GRIN2D O15399 2/20 0.39
GRIN3B O60391 2/20 0.39
GRIN2C Q14957 2/20 0.39
GRIN3A Q8TCU5 2/20 0.39
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
MGLL Q99685 2/20 0.37
POLB P06746 1/20 0.37
PPARG P37231 1/20 0.37
KMT2A Q03164 1/20 0.37
NCOA2 Q15596 1/20 0.37
NCOA1 Q15788 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15477388 0.86 SMN1; SMN2 (0.48) ALDH1A1RAB9ASMN1; SMN2GRIN2BNPC1
SCHEMBL4239619 0.81 GAA (0.65) GAAGRIN2BGRIN2AGRIN1GRIN2D
SCHEMBL4245344 0.80 GAA (0.48) ALDH1A1SMN1; SMN2GAAGRIN2BGRIN2A
SCHEMBL27670166 0.80 MAOB (0.54) GAAGRIN2BGRIN2AGRIN1GRIN2D
SCHEMBL4247838 0.79 PARP10 (0.59) GAAGRIN2BGRIN2AGRIN1GRIN2D
SCHEMBL8554777 0.77 ACHE (0.56) ALDH1A1RAB9ASMN1; SMN2NPC1LMNA
SCHEMBL4240708 0.74 PARP10 (0.54) GRIN2BGRIN1
SCHEMBL4777512 0.74 ALDH1A1 (0.44) ALDH1A1RAB9ASMN1; SMN2GAANPC1
SCHEMBL4243148 0.74 GAA (0.55) ALDH1A1GAAGRIN2BGRIN2AGRIN1
SCHEMBL4243512 0.74 GAA (0.55) GAAGRIN2BGRIN2AGRIN1GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090170901-A1 Benzoyl Urea Derivatives RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2009-07-02 US claimed
US-20090170901-A1 Benzoyl Urea Derivatives RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2009-07-02 US disclosed
EP-1771429-A1 NEW BENZOYL UREA DERIVATIVES RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2007-04-11 EP disclosed
WO-2006010966-A1 NEW BENZOYL UREA DERIVATIVES Richter Gedeon Vegyészeti Gyár Rt. (HU) 2006-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170901-A1 Benzoyl Urea Derivatives OPRM1, GRIN2C, GRIN3A ALDH1A1 2126/4885RAB9A 3544/4885SMN1; SMN2 3077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.